Changes to Non-Executive Directors

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Feb 10, 2006

GW Pharmaceuticals today announces the appointment of Mr David Morrison as a non-executive director with immediate effect. Mr Morrison replaces Mr Peter Mountford, who today resigns as a non-executive director.

David Morrison is Chief Executive of Prospect Investment Management, an investment advisory firm. Clients of Prospect are shareholders in GW. David began his career with 3i Group, followed by 13 years with Abingworth Management Limited. David is also a non-executive director of a large number of public and private companies, including Paypoint plc, Venture Production plc, BlueHeath Holdings plc, MessageLabs Group Ltd, MGT plc, Standard Life Equity Investment Trust plc and UK Specialist Hospitals Ltd.

Dr Geoffrey Guy, Executive Chairman of GW, said: '”We are delighted to welcome David to the Board of GW. David is a valued advisor to, and investor in, a range of public and private companies and his expertise is ideally suited to GW as it embarks on the next phase of its growth.”

Commenting on the resignation of Peter Mountford, Dr Guy, said, “Peter has been a non-executive director of GW for five years. Peter’s extensive experience as an investor in and advisor to emerging companies was instrumental in helping us to successfully float on the AIM market in June 2001 and he has continued to be a valuable member of the Board since that time. Everyone at GW joins me in thanking Peter and wishing him all the best and continued success in his other business ventures.”

Peter Mountford owns warrants to subscribe for up to 51,765 ordinary shares in the capital of the Company which originally expired on 14 January 2006. The Board has agreed to extend the exercise period such that the warrants may be exercised at any time on or before 14 January 2008.

- Ends -


GW Pharmaceuticals plc  + 44 (0)1980 557000
Dr Geoffrey Guy, Executive Chairman

Justin Gover, Managing Director  

Weber Shandwick Square Mile  + 44 (0)20 7067 0700

Kevin Smith



Current directorships:

UK Specialist Hospitals Limited

Shepton Mallet Treatment Centre Limited

Blueheath Holdings plc

Standard Life Equity Investment Trust plc

R.H.S. Enterprises Limited

Vibration Technology Limited

Luckington Properties Limited

MGt plc

MGt Trustee Limited

MessageLabs Group Limited

Venture Production plc

PayPoint plc

PayPoint Collections Limited

PayPoint Retails Solutions Limited

PayPoint Network Limited

The Houghton Club Limited

Prospect Investment Management Limited

Former directorships held since 8 February 2001:

Blue Heath Direct Limited

Arundel House Enterprises Limited

There are no further disclosures to be made in respect of David Morrison pursuant to paragraph (f) of Schedule 2 of the AiM Rules for companies.

Recent News